Skip to main content
Erschienen in: Journal of Genetic Counseling 5/2013

01.10.2013 | Original Research

Effect of Direct-to-Consumer Genetic Tests on Health Behaviour and Anxiety: A Survey of Consumers and Potential Consumers

verfasst von: Corin Egglestone, Anne Morris, Ann O’Brien

Erschienen in: Journal of Genetic Counseling | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Direct-to-consumer (DTC) genetic tests can be purchased over the internet. Some companies claim to provide relative genetic risks for various diseases and thus encourage healthy behaviour. There are concerns that exposure to such information may actually discourage healthy behaviour or increase health anxiety. An online survey was conducted (n = 275). Respondents were composed of individuals who had purchased a DTC genetic test and received their results (consumers, n = 189), as well as individuals who were either awaiting test results or considering purchasing a test (potential consumers, n = 86). Consumers were asked if their health behaviour or health anxiety had changed after receiving their results. Respondents’ current health behaviour and health anxiety were queried and compared. In total, 27.3 % of consumers claimed a change in health behaviour, all either positive or neutral, with no reported cessation of any existing health behaviour. A change in health anxiety was claimed by 24.6 % of consumers, 85.3 % of which were a reduction. Consumers had significantly better health behaviour scores than potential consumers (p = 0.02), with no significant difference in health anxiety. This study points towards an association between receipt of DTC genetic test results and increased adoption of healthy behaviours for a minority of consumers based on self-report, with more mixed results in relation to health anxiety.
Literatur
Zurück zum Zitat Bloss, C. S., Ornowski, L., Silver, E., et al. (2010). Consumer perceptions of direct-to-consumer personalized genomic risk assessments. Genetics in Medicine, 12(9), 556–566.PubMedCrossRef Bloss, C. S., Ornowski, L., Silver, E., et al. (2010). Consumer perceptions of direct-to-consumer personalized genomic risk assessments. Genetics in Medicine, 12(9), 556–566.PubMedCrossRef
Zurück zum Zitat Bloss, C. S., Darst, D. F., Topol, E. J., & Schork, N. J. (2011). Direct-to-consumer personalized genomic testing. Human Molecular Genetics, 20(R2), R132–R141.PubMedCrossRef Bloss, C. S., Darst, D. F., Topol, E. J., & Schork, N. J. (2011). Direct-to-consumer personalized genomic testing. Human Molecular Genetics, 20(R2), R132–R141.PubMedCrossRef
Zurück zum Zitat Bloss, C. S., Schork, N. J., & Topol, E. J. (2011). Effect of direct-to-consumer genomewide profiling to assess disease risk. The New England Journal of Medicine, 364(6), 524–534.PubMedCrossRef Bloss, C. S., Schork, N. J., & Topol, E. J. (2011). Effect of direct-to-consumer genomewide profiling to assess disease risk. The New England Journal of Medicine, 364(6), 524–534.PubMedCrossRef
Zurück zum Zitat Boyatzis, R.E. (1998). Transforming qualitative information. Thousand Oaks, CA: Sage Publications, 4, 29–53. Boyatzis, R.E. (1998). Transforming qualitative information. Thousand Oaks, CA: Sage Publications, 4, 29–53.
Zurück zum Zitat Gordon, E.S., Griffin, G., Wawak, L., Pang, H., Gollust, S.E., & Bernhardt, B.A. (2012). “It’s not like judgement day”: public understanding of and reactions to personalized genomic risk information. Journal of Genetic Counseling, 21(3), 423–432. Gordon, E.S., Griffin, G., Wawak, L., Pang, H., Gollust, S.E., & Bernhardt, B.A. (2012). “It’s not like judgement day”: public understanding of and reactions to personalized genomic risk information. Journal of Genetic Counseling, 21(3), 423–432.
Zurück zum Zitat Hilgart, J. S., Coles, B., & Iredale, R. (2012). Cancer genetic risk assessment for individuals at risk of familial breast cancer. Cochrane Database of Systematic Reviews, 15(2), CD003721. Hilgart, J. S., Coles, B., & Iredale, R. (2012). Cancer genetic risk assessment for individuals at risk of familial breast cancer. Cochrane Database of Systematic Reviews, 15(2), CD003721.
Zurück zum Zitat Kaufman, D.J., Bollinger, J.M., Dvoskin, R.L., & Scott, J.A. (2012). Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing. Journal of Genetic Counseling, 21(3), 413–422. Kaufman, D.J., Bollinger, J.M., Dvoskin, R.L., & Scott, J.A. (2012). Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing. Journal of Genetic Counseling, 21(3), 413–422.
Zurück zum Zitat Lachance, C. R., Erby, L. A. H., Ford, B. M., Allen, V. C., Jr., & Kaphingst, K. A. (2010). Informational content, literacy demands, and usability of websites offering health-related genetic tests directly to consumers. Genetics IN Medicine, 12(5), 304–312.PubMedCrossRef Lachance, C. R., Erby, L. A. H., Ford, B. M., Allen, V. C., Jr., & Kaphingst, K. A. (2010). Informational content, literacy demands, and usability of websites offering health-related genetic tests directly to consumers. Genetics IN Medicine, 12(5), 304–312.PubMedCrossRef
Zurück zum Zitat McBride, C. M., Wade, C. H., & Kaphingst, K. A. (2010). Consumers’ views of direct-to-consumer genetic information. Annual Review of Genomics and Human Genetics, 22(11), 427–446.CrossRef McBride, C. M., Wade, C. H., & Kaphingst, K. A. (2010). Consumers’ views of direct-to-consumer genetic information. Annual Review of Genomics and Human Genetics, 22(11), 427–446.CrossRef
Zurück zum Zitat Murray, A. B., Carson, M. J., Morris, C. A., & Beckwith, J. (2010). Illusions of scientific legitimacy: misrepresented science in the direct-to-consumer genetic-testing marketplace. Trends in Genetics, 26(11), 459–461.CrossRef Murray, A. B., Carson, M. J., Morris, C. A., & Beckwith, J. (2010). Illusions of scientific legitimacy: misrepresented science in the direct-to-consumer genetic-testing marketplace. Trends in Genetics, 26(11), 459–461.CrossRef
Zurück zum Zitat Roberts, J. S., Christensen, K. D., & Green, R. C. (2011). Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics. Clinical Genetics, 80(5), 407–414. Roberts, J. S., Christensen, K. D., & Green, R. C. (2011). Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics. Clinical Genetics, 80(5), 407–414.
Zurück zum Zitat Samuel, G. N., Jordens, C. F. C., & Kerridge, I. (2010). Direct-to-consumer personal genome testing: ethical and regulatory issues that arise from wanting to ‘know’ your DNA. Internal Medicine Journal, 40(3), 220–224.PubMedCrossRef Samuel, G. N., Jordens, C. F. C., & Kerridge, I. (2010). Direct-to-consumer personal genome testing: ethical and regulatory issues that arise from wanting to ‘know’ your DNA. Internal Medicine Journal, 40(3), 220–224.PubMedCrossRef
Zurück zum Zitat Singleton, A., Erby, L. H., Foisie, K. V., & Kaphingst, K. A. (2012). Informed choice in direct-to-consumer genetic testing (DTCGT) websites: a content analysis of benefits, risks, and limitations. Journal of Genetic Counselling, 21(3), 433–439.CrossRef Singleton, A., Erby, L. H., Foisie, K. V., & Kaphingst, K. A. (2012). Informed choice in direct-to-consumer genetic testing (DTCGT) websites: a content analysis of benefits, risks, and limitations. Journal of Genetic Counselling, 21(3), 433–439.CrossRef
Zurück zum Zitat Smerecnik, C., Grispen, J. E., & Quaak, M. (2012). Effectiveness of testing for genetic susceptibility to smoking-related diseases on smoking cessation outcomes: a systematic review and meta-analysis. Tobacco Control, 21(3), 347–354.PubMedCrossRef Smerecnik, C., Grispen, J. E., & Quaak, M. (2012). Effectiveness of testing for genetic susceptibility to smoking-related diseases on smoking cessation outcomes: a systematic review and meta-analysis. Tobacco Control, 21(3), 347–354.PubMedCrossRef
Zurück zum Zitat Spencer, D. H., Lockwood, C., Topol, E., et al. (2011). Direct-to-consumer genetic testing: reliable or risky? Clinical Chemistry, 57(12), 1641–1644.PubMedCrossRef Spencer, D. H., Lockwood, C., Topol, E., et al. (2011). Direct-to-consumer genetic testing: reliable or risky? Clinical Chemistry, 57(12), 1641–1644.PubMedCrossRef
Metadaten
Titel
Effect of Direct-to-Consumer Genetic Tests on Health Behaviour and Anxiety: A Survey of Consumers and Potential Consumers
verfasst von
Corin Egglestone
Anne Morris
Ann O’Brien
Publikationsdatum
01.10.2013
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 5/2013
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-013-9582-6

Weitere Artikel der Ausgabe 5/2013

Journal of Genetic Counseling 5/2013 Zur Ausgabe

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.